Diopter Technologies Announces Completed of Clinical Study for Revolutionary Dissolving Amniotic Membrane Biopolymer Contact Lens for Ocular Surface Disease Treatment
Groundbreaking device accelerates healing while eliminating extra office visits BOSTON, MA – July 10, 2025 – Diopter Technologies today announced the completion of early clinical studies of its innovative dissolving amniotic membrane and biopolymer contact lens, a first-of-its-kind therapeutic device designed to treat ocular surface diseases including dry eye syndrome, corneal trauma injuries, and post-surgical […]
Revolutionizing Eye Care: Diopter Corp. Showcases Groundbreaking Technology at DOD Vision Injury Research Forum
Cambridge, MA – November 27, 2024 — In a move that could transform the landscape of ocular treatments, Diopter Corp is set to unveil its cutting-edge drug delivery technology at the prestigious Department of Defense 2024 Vision Injury Research Forum (VIRF). This virtual conference, scheduled for December 13, 2024, brings together key stakeholders from the […]
